Healthcare - Biotechnology - NASDAQ - US
$ 3.345
-6.95 %
$ 439 M
Market Cap
-1.54
P/E
BALANCE SHEET
194 M
ASSETS
60.8 M
LIABILITIES
133 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Prime Medicine, Inc.
| Current Assets | 143 M |
| Cash & Short-Term Investments | 122 M |
| Receivables | 0 |
| Other Current Assets | 21.3 M |
| Non-Current Assets | 50.9 M |
| Long-Term Investments | 0 |
| PP&E | 36.6 M |
| Other Non-Current Assets | 14.3 M |
| Current Liabilities | 56.4 M |
| Accounts Payable | 19.5 M |
| Short-Term Debt | 18.6 M |
| Other Current Liabilities | 18.3 M |
| Non-Current Liabilities | 4.36 M |
| Long-Term Debt | 8.71 M |
| Other Non-Current Liabilities | -4.36 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 41.6 | 187.6 | 185.4 | 37.0 | 8.6 |
| Short Term Investments | 80.1 | 106.3 | 84.2 | 16.4 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 21.3 | 2.7 | 1.9 | 74 K | 50 K |
| Total Current Assets | 143.0 | 293.9 | 270.6 | 53.4 | 8.7 |
| PP&E | 36.6 | 48.6 | 15.7 | 0.6 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 13.5 | 13.1 | 0 | 0 |
| Other Long Term Assets | 14.3 | (52.8) | 2.5 | 0.8 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 193.9 | 360.3 | 301.9 | 54.8 | 8.7 |
| LIABILITIES | |||||
| Accounts Payable | 19.5 | 4.3 | 1.4 | 0.2 | 0 |
| Short Term Debt | 18.6 | 11.7 | 7.3 | 0 | 0 |
| Other Current Liabilities | 18.3 | 10.7 | 49.2 | 19.2 | 7.3 |
| Total Current Liabilities | 56.4 | 26.7 | 58.0 | 19.4 | 7.3 |
| Long Term Debt | 8.7 | 17.1 | 3.1 | 0 | 0 |
| Deferred Tax Income | 0 | 0.3 | 1.2 | 1.9 | 0 |
| Other Liabilities | (4.4) | 0 | 0 | 0 | 0 |
| Total Liabilities | 60.8 | 360.3 | 62.3 | 21.3 | 7.3 |
| EQUITY | |||||
| Common Stock | 2 K | 2 K | 1 K | 1 K | 1 K |
| Retained Earnings | (491.3) | (293.2) | (171.4) | (6.0) | (2.6) |
| Other Accumulative Comprehensive Income/Loss | 15 K | (0.4) | 27 K | 1 K | 0 |
| Total Equity | 133.1 | (293.6) | 239.6 | 33.5 | 1.4 |
| Total Liabilities and Equity | 193.9 | 360.3 | 301.9 | 54.8 | 8.7 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 91.0 | 97.2 | 64.9 | 71.8 | 95.7 |